Seroatlas · Human Serome Atlas

TNFRSF25

Tumor necrosis factor receptor superfamily member 25

Also known as: APO-3, DDR3, DR3, LARD, TNFRSF12, TNR25_HUMAN, TR3, TRAMP, WSL-1, WSL-LR

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q93038
Gene
TNFRSF25
Ensembl
ENSG00000215788
Chromosome
1
Canonical length
417 aa
Protein class
Predicted membrane proteins, Predicted secreted proteins
Subcellular location
Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites
Secretome location
Secreted - unknown location
Quaternary structure
Homodimer

OverviewNCBI Gene

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is expressed preferentially in the tissues enriched in lymphocytes, and it may play a role in regulating lymphocyte homeostasis. This receptor has been shown to stimulate NF-kappa B activity and regulate cell apoptosis. The signal transduction of this receptor is mediated by various death domain containing adaptor proteins. Knockout studies in mice suggested the role of this gene in the removal of self-reactive T cells in the thymus. Multiple alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported, most of which are potentially secreted molecules. The alternative splicing of this gene in B and T cells encounters a programmed change upon T-cell activation, which predominantly produces full-length, membrane bound isoforms, and is thought to be involved in controlling lymphocyte proliferation induced by T-cell activation. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

417 residues, UniProt reviewed canonical sequence.

>Q93038|TNFRSF25
     1  MEQRPRGCAA VAAALLLVLL GARAQGGTRS PRCDCAGDFH KKIGLFCCRG CPAGHYLKAP
    61  CTEPCGNSTC LVCPQDTFLA WENHHNSECA RCQACDEQAS QVALENCSAV ADTRCGCKPG
   121  WFVECQVSQC VSSSPFYCQP CLDCGALHRH TRLLCSRRDT DCGTCLPGFY EHGDGCVSCP
   181  TSTLGSCPER CAAVCGWRQM FWVQVLLAGL VVPLLLGATL TYTYRHCWPH KPLVTADEAG
   241  MEALTPPPAT HLSPLDSAHT LLAPPDSSEK ICTVQLVGNS WTPGYPETQE ALCPQVTWSW
   301  DQLPSRALGP AAAPTLSPES PAGSPAMMLQ PGPQLYDVMD AVPARRWKEF VRTLGLREAE
   361  IEAVEVEIGR FRDQQYEMLK RWRQQQPAGL GAVYAALERM GLDGCVEDLR SRLQRGP

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against TNFRSF25 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.47
Highest tissue expression
42 nTPM

Expression across tissuesHPA

Tissue

  • cerebellum: 42 nTPM
  • spleen: 40 nTPM
  • pituitary gland: 27 nTPM
  • skin: 24 nTPM
  • esophagus: 9 nTPM
  • heart muscle: 8 nTPM

Single-cell type

  • innate lymphoid cells: 132 nCPM
  • corticotrophs: 74 nCPM
  • brain excitatory neurons: 59 nCPM
  • adipocytes: 37 nCPM
  • thyrotrophs: 35 nCPM
  • adrenal medulla cells: 32 nCPM

Immune cell

  • T-reg: 7.9 nTPM
  • MAIT T-cell: 5.6 nTPM
  • memory CD4 T-cell: 4.4 nTPM
  • naive CD4 T-cell: 4.4 nTPM
  • memory CD8 T-cell: 2.2 nTPM
  • gdT-cell: 1 nTPM

Brain region

  • cerebellum: 19 nTPM
  • cerebral cortex: 6.8 nTPM
  • choroid plexus: 6.5 nTPM
  • hippocampal formation: 6.3 nTPM
  • hypothalamus: 5.8 nTPM
  • pons: 5.6 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.6
gnomAD pLI
0.01
gnomAD missense Z
1.57
DepMap mean gene effect
-0.02
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of TNFRSF25 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads TNFRSF25 as an antibody target. Whether an autoantibody or antibody against TNFRSF25 could matter depends on whether native TNFRSF25 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

TNFRSF25 is annotated at the cell surface, where native TNFRSF25 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label TNFRSF25 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/TNFRSF25. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...